News

Sleeping on the back or side through the 30th week of pregnancy does not appear to increase the risk of stillbirth, reduced size at birth, or high blood pressure disorders of pregnancy, suggests an analysis funded by the NICHD.

Blood levels of omega-6 fatty acids produced in the body could influence the likelihood of developing gestational diabetes, suggests a study by researchers at the National Institutes of Health and other institutions. However, the researchers found no association with gestational diabetes from consuming foods containing omega-6 fatty acids, such as vegetable oils, nuts, and seeds.

Pregnant women who are exposed to higher air pollution levels during their second pregnancy, compared to their first one, may be at greater risk of preterm birth, according to researchers at the National Institutes of Health.

Improved data reporting among the factors critical to reducing life-threatening complications of pregnancy and childbirth

Infants born to mothers taking the drug naltrexone to treat opioid use disorder showed no signs of drug withdrawal and had shorter hospital stays than infants born to mothers undergoing the standard treatment, according to a small study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Elevated blood pressure in the first trimester of pregnancy, or an increase in blood pressure between the first and second trimesters, raises the chances of a high blood pressure disorder of pregnancy, according to a study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health.

Long-acting contraception after childbirth could help teens avoid short-interval pregnancies, suggests NIH-funded study.

Patient advocates, healthcare providers and researchers help map a future research agenda aimed at reducing maternal mortality and severe morbidity.

In an editorial, Diana W. Bianchi, M.D., NICHD Director and Matthew W. Gillman, M.D., S.M., emphasize that women and children bear a substantial burden of the U.S. opioid epidemic and that coordinated, long-term research is essential to filling knowledge gaps about how opioids affect women and children.

NICHD was established more than 50 years ago to help understand maternal health and improve pregnancy outcomes. These selected advances highlight NICHD’s contributions to advancing the health and well-being of pregnant women, mothers, and families everywhere.

Group seeks to enhance testing of therapeutics used by pregnant women and nursing mothers.

Each year in the United States, 700 women die from pregnancy or childbirth complications – one of the highest maternal death rates in the developed world. Listen to Milestones interview with Dr. Juanita Chinn from NICHD’s Population Dynamics Branch.

Some preterm infants produce a protein in response to inflammation that appears to protect them against birth-related brain injury, according to an analysis by researchers funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The substance, known as haptoglobin, is present in umbilical cord blood. Future studies could determine if testing preterm infants for haptoglobin identifies those who would benefit from interventions to prevent brain injury or lessen its effects.

On April 8, 2019, join community organizations and healthcare professionals to discuss strategies for reducing the rising rate of maternal deaths in the United States.

Secretary of Health and Human Services renews task force for an additional two years. Task force members will offer guidance and advice on implementing 15 recommendations they submitted in September 2018.

An analysis of a previous study has found more evidence to support giving the steroid betamethasone to pregnant women at risk of late-preterm delivery (between 34 and 36 weeks of gestation), according to a network funded by the National Institutes of Health. Hospital stays for infants whose mothers received the drug cost less on average, compared to stays for infants whose mothers did not take the drug.

Newborns infected with herpes simplex virus (HSV) can be appropriately treated with acyclovir, a drug typically prescribed to adults for the treatment of HSV infections.

In 2018, researchers funded by NICHD made significant progress in advancing the health and well-being of infants, children, teenagers, and adults across the United States and around the world.